BOMC, The company in the past has had a reverse stock split. Investors fear management will do this again. Company will eventually need a Phase 3 clinical trial so it is estimated results from such may not be out until 2025-2026. If all goes well and substantial dilution is avoided this stock could be a 100X gainer. The best way to play this is to simply buy some stock and then sell call options until it is called away. Might not get a 100X but could get you a double sooner or later. Their only drug looks to be a winner if they can get it through the gauntlet and perhaps reap the rewards of a BO.